首页> 外文期刊>Current respiratory medicine reviews >Focus on Pleiotropic Role of HMGB1 in the Onset of Allergic and Non- Allergic Respiratory Diseases
【24h】

Focus on Pleiotropic Role of HMGB1 in the Onset of Allergic and Non- Allergic Respiratory Diseases

机译:重点关注HMGB1在过敏性和非过敏性呼吸系统疾病发作中的抗脂肪作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: HMGB1 is a marker of inflammation that belongs to the alarmins family promoting an immediate activation of the innate immune response, such as chemotaxis and proinflammatory cytokine release, in response to tissue damage. The aim of this mini review is summarized what isknown about the role of HMGB1 in onset and development of allergic and not allergic respiratory disorders. Methods: A literature search of electronic database was udertaken for the major studies published from 2012 to date. The databases searched were: PubMed and Science Direct. We usedthe keywords: "HMGB1, respiratory diseases, airway diseases, allergic respiratory diseases, rhinitis, nasal polyposis, asthma, infectious diseases, COPD, cystic fibrosis " Results: Of 207 reviewed reports, 43 were included in this systematic review. Studies look at HMGB1 asa new molecule orchestrating a homeostatic defensive response essential for the occurrence, progression, and persistence both of allergic and not allergic respiratory diseases. In particular, HMGB1 has been implicated in the pathophysiology both of allergic rhinitis and asthma as well as inchronic rhinitis, nasal polyposis, infectious diseases and cystic fibrosis. Conclusion: HMGB1, as causal molecule for several diseases, has stimulated an increasing interest in the field of inflammation research, providing new useful data for understanding disease processes as well asopening scenarios for new therapeutic strategies.
机译:背景:HMGB1是炎症的标志物属于警报素家族促进先天免疫应答的立即激活,如趋化性和促炎细胞因子的释放,响应于组织损伤。这种迷你审查的目的是总结什么isknown约HMGB1的发病与过敏的发展,而不是过敏性呼吸系统疾病的作用。方法:文献检索电子数据库,为udertaken的出版从2012年至今的主要研究。搜索的数据库是:PubMed和科学指导。我们usedthe关键词:“HMGB1,呼吸系统疾病,呼吸道疾病,过敏性呼吸道疾病,鼻炎,鼻息肉,哮喘,感染性疾病,慢性阻塞性肺病,囊性纤维化”结果:207份检讨报告中,43被列入此系统的审查。研究着眼于HMGB1 ASA新分子精心策划的发生,发展一个自我平衡的防御性反应必不可少的,持久性都过敏和不过敏呼吸系统疾病。特别是,HMGB1已牵涉在两个变应性鼻炎和哮喘,以及inchronic鼻炎,鼻息肉病,感染性疾病和囊性纤维化的病理生理学。结论:HMGB1,对于一些疾病的因果分子,刺激了炎症研究领域的兴趣越来越大,对于了解疾病过程,作为新的治疗策略以及asopening场景提供了新的有用的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号